Just, Alanna L.
Meng, Chun http://orcid.org/0000-0003-0145-6627
Smith, Dana G.
Bullmore, Edward T. http://orcid.org/0000-0002-8955-8283
Robbins, Trevor W.
Ersche, Karen D. http://orcid.org/0000-0002-3203-1878
Funding for this research was provided by:
RCUK | Medical Research Council (G0701497)
Gates Cambridge Trust
Wellcome Trust (105602/Z/14/Z)
Article History
Received: 4 April 2018
Revised: 19 October 2018
Accepted: 9 December 2018
First Online: 4 February 2019
Conflict of interest
: This research was funded by a Medical Research Council (MRC) grant (G0701497), and conducted within the Behavioural and Clinical Neuroscience Institute (BCNI), which is jointly funded by the MRC and Wellcome Trust. A.L.J. was supported by the Gates Cambridge Trust, D.G.S. by a studentship from the Cambridge Overseas Trust, and C.M. by the Wellcome Trust (105602/Z/14/Z) and the NIHR Cambridge Biomedical Research Centre. E.T.B. is employed part-time by GlaxoSmithKline and part-time by the University of Cambridge, and serves as the Head of Research and Development at the Cambridgeshire and Peterborough NHS Foundation Trust. T.W.R. consults for Cambridge Cognition, Lundbeck, Otsuka, and Mundipharma. He also holds a research grant from Shionogi. The authors declare no additional conflict of interests.